Skip to main content

Table 2 Risk assessment, prophylaxis use and low-molecular weight heparin use by hospital in 2009 and 2010

From: The implementation of nice guidance on venous thromboembolism risk assessment and prophylaxis: a before-after observational study to assess the impact on patient safety across four hospitals in England

Hospital

Year

Risk assessment,%

Prophylaxis use,%

LMWH use,%

All

2009

51.5

80.4

49.8

 

2010

79.2

85.8

60.3

A

2009

43.1

91.2

67.6

 

2010

90.2

97.1

60.8

B

2009

58.8

76.5

63.7

 

2010

83.3

82.4

52.9

C

2009

32.4

71.6

24.5

 

2010

67.6

79.4

67.6

D

2009

71.6

82.4

43.1

 

2010

75.5

84.3

59.8

  1. *sample size is 102 for each hospital and year.
  2. Data in each year collected over a 3-week period.
  3. LMWH: low-molecular weight heparin.